- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03492957
PHysical Activity for Non-ambulatory Stroke Survivors: Feasibility Study (PHANSS)
PHysical Activity for Non-ambulatory Stroke Survivors (PHANSS-2): Developing a Feasible and Acceptable Intervention for Stroke Survivors Who Cannot Walk Independently
Study Overview
Detailed Description
Background:
Physical activity interventions after stroke are needed because stroke survivors are under-active; their average physical fitness level is about 50% of sedentary healthy controls. This adversely affects vascular risk factor profiles, disability and participation, problems that are all likely to be exacerbated in stroke survivors who are unable to walk. Fitness can be improved after stroke through cardiorespiratory training. This also improves psychosocial functioning and adaptation to life after stroke. Community-based services for exercise after stroke are developing throughout the UK. However, current evidence, associated guidelines and exercise professional training mainly pertain to ambulatory stroke survivors; non-ambulatory stroke survivors have hardly been involved in this area of research. In this study, we define "non-ambulatory" as requiring at least "continuous or intermittent support of one person to help with balance or coordination" (i.e. Functional Ambulatory Category ≤ 2).
Study aim:
The aim of this study is to design a physical activity programme for non-ambulatory stroke survivors (delivered via either community-based groups or a home-based individual programme) and evaluate its feasibility, acceptability, preliminary and adverse effects. The study will also explore the views of non-ambulatory stroke survivors and their carers on: needs, personal goals, barriers, and motivators, experiences of programme participated in and preferred format (i.e. home-based individual/ community-based groups).
Study design:
Mixed-methods, observational feasibility study. This study will incorporate qualitative interviews/focus groups to explore the experiences of the programme participants are taking part in and their thoughts and views of PA after stroke. Interviews and focus groups will be conducted throughout the physical activity programme.
Participant recruitment:
Participants will be recruited by the Scottish Stroke Research Network (SRN) via: databases and electronic patient medical/nursing/AHP notes, records of discharges from acute stroke wards to off-site rehabilitation units and word of mouth among AHPs., within NHS Lanarkshire.
Participants will also be recruited via non-NHS sites: local community stroke groups, social media, stroke charities, press releases and related media and care homes.
Study setting:
Glasgow Caledonian University will be used for the community-based group programme and focus groups/interviews.
Participants' own home setting will be used for the home-based, individual programme and interviews.
Study participants:
Non-ambulatory stroke survivors and their carers (where applicable) living at home or in care homes.
Study outcomes:
Outcomes will include measures of disability, ADL, strength, anxiety and depression, sedentary behaviour, self-efficacy, health status, attainment of individual goals, as well as carer burden (where appropriate).
Feasibility will be assessed by numbers of participants invited to participate, accepting and being recruited into the study, completing the intervention, programme adherence and drop outs. Safety data will be examined using data on adverse effects reported by participants.
Study duration: 12 months.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria (stroke survivors):
- Age 18 years or over
- Clinical diagnosis of stroke
- Non-ambulatory, defined as requiring at least "continuous or intermittent support of one person to help with balance or coordination" (i.e. Functional Ambulatory Category ≤ 2) most of the time.
- Able to give informed consent (by proxy if appropriate)
- Able to travel via private taxi to community venue (for group exercise, if preferred)
- For care home residents: participant must not be participating in any structured form of PA run within their care home.
- Participant residing in private home or care home (must be discharged from in-patient care at start of intervention)
Exclusion Criteria (stroke survivors):
- Judged by treating GP to be too unwell to participate
- Uncontrolled medical condition that contraindicates exercise e.g. uncontrolled cardiac condition
- Severe cognitive impairment (unable to follow and understand instructions)
Inclusion criteria (carers):
- Able to give informed consent
Exclusion criteria (carers):
- Not well enough to participate (as per self-report)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Physical activity
A tailored, person-centred, 12-week, chair-based exercise intervention to increase physical activity and fitness.
Dose: one face-face session with a qualified physiotherapist plus two independent sessions per week.
This is combined with education on self-management, self-efficacy and lifestyle change.
There is no control group ion this feasibility study.
|
A tailored, person-centred, 12-week, chair-based exercise intervention to increase physical activity and fitness.
Dose: one face-face session with a qualified physiotherapist plus two independent sessions per week.
This is combined with education on self-management, self-efficacy and lifestyle change.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Canadian Occupational Performance Measure (COPM)
Time Frame: 3-month follow-up
|
Person-centred tool for goal setting and evaluation
|
3-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Barthel Index (BI)
Time Frame: 3-month follow-up
|
Measure to evaluate independence in activities of daily living
|
3-month follow-up
|
Stroke Impact Scale (SIS)
Time Frame: 3-month follow-up
|
Measure to evaluate impact of intervention on stroke-related impairments, activity limitations and participation restrictions
|
3-month follow-up
|
Stroke Self-Efficacy questionnaire (SSEQ)
Time Frame: 3-month follow-up
|
Measure to evaluate level of confidence
|
3-month follow-up
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 3-month follow-up
|
Measure to evaluate levels of anxiety and depression
|
3-month follow-up
|
Motricity Index (MI)
Time Frame: 3-month follow-up
|
Clinical evaluation of muscle strength in both affected and non-affected upper and lower limbs
|
3-month follow-up
|
Force measurements
Time Frame: 3-month follow-up
|
Quantitative measurements of muscle force in quadriceps and hamstring muscles in both affected and unaffected lower limbs using dynamometry
|
3-month follow-up
|
Caregiver Burden Scale (CBS)
Time Frame: 3-month follow-up
|
A questionnaire to evaluate carer burden
|
3-month follow-up
|
Activity data
Time Frame: 3-month follow-up
|
Quantitative data from an activity monitor to measure sedentary behaviour
|
3-month follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Frederike MJ van Wijck, PhD, Glasgow Caledonian University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SHLS1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on Physical activity
-
Health Education Research Foundation (HERF)CompletedQuality of LifePakistan
-
Zohra Institute of Health SciencesCompletedPhysical Activity and StressPakistan
-
Centre Hospitalier Universitaire DijonWithdrawn
-
Fundacion para la Investigacion y Formacion en...CompletedImpaired CognitionSpain
-
Cardenal Herrera UniversityRecruiting
-
Istituti Clinici Scientifici Maugeri SpAActive, not recruiting
-
Assaf-Harofeh Medical CenterBen-Gurion University of the NegevUnknown
-
AUSL Romagna RiminiFondazione IRCCS Istituto Nazionale dei Tumori, MilanoRecruitingNon-Small Cell Lung CancerItaly
-
Fundación para la Investigación del Hospital Clínico...CompletedObesity | Severe Mental Disorder
-
Augusta UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Kansas... and other collaboratorsCompletedMental Disorders, SevereUnited States